Jasper Therapeutics stockholders approve reverse stock split authorization up to 1-for-10

Jasper Therapeutics, Inc.

Reverse split proposal approved with 91,108,798 votes for, 873,917 against, 32,292 abstentions.
Board may implement split at ratio between 1-for-3 and 1-for-10 at any time before Dec 15, 2024.
Adjournment proposal also approved but was not needed; 91,306,235 votes for, 669,886 against.
Approximately 82% of outstanding shares were represented at the Dec 15 special meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Jasper Therapeutics, Inc. shareholders approved Approve an amendment to the Certificate of Incorporation to effect a reverse stock split within a range of 1-for-3 to 1-for-10 at the 2023-12-15 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-12-15

Exact text from the filing

On December 15, 2023, Jasper Therapeutics, Inc. (the “Company”) held a Special Meeting of Stockholders

View on SEC.gov

220 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Jasper Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-097100

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.